Logo

Harvard Bioscience, Inc.

HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis… read more

Healthcare

Medical Instruments & Supplies

22 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.44

Price

+1.41%

$0.00

Market Cap

$19.803m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$88.750m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$57.406m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.30

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$15.733m

$80.093m

Assets

$64.360m

Liabilities

$43.314m

Debt
Debt to Assets

54.1%

-0.9x

Debt to EBITDA
Free Cash Flow

$4.920m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases